4.2 Article

Pupil Response Biomarkers for Early Detection and Monitoring of Alzheimer's Disease

Journal

CURRENT ALZHEIMER RESEARCH
Volume 10, Issue 9, Pages 931-939

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/15672050113106660163

Keywords

Alzheimer's; aging; diagnosis; pupil; screening; vision

Funding

  1. Science and Industry Endowment Fund

Ask authors/readers for more resources

Introduction A screening process that could provide early and accurate diagnosis or prognosis for Alzheimer's disease (AD) would enable earlier intervention, and enable current and future treatments to be more effective. Ocular pathology and changes to vision and ocular function are being investigated for early detection and monitoring of AD. Objective To explore the relationship between pupil flash response (PFR) parameters, AD and brain amyloid plaque burden. Methods NineteenADandseventyhealthy control (HC) participants were recruited from the Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing. Thepotential correlations betweenPFRparameters and1) AD and 2) brain amyloid plaque burden in the HC group (as a pre-clinical feature of AD), were investigated in this study. Results Our results demonstratestatistically significant relationships between PFR parameters, neocortical plaque burden and AD. A logistical model combining PFR parameters provided AD-classification performance with sensitivity 84.1%, specificity 78.3% and area under the curve 89.6%. Furthermore, some of the AD specific PFR parameters were also associated with-neocortical plaque burden in pre-clinical AD. Conclusions These PFR changes show potential as an adjunct for non-invasive, cost-effective screening for pre-clinical AD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort

Pratishtha Chatterjee, Steve Pedrini, James D. Doecke, Rohith Thota, Victor L. Villemagne, Vincent Dore, Abhay K. Singh, Penghao Wang, Stephanie Rainey-Smith, Christopher Fowler, Kevin Taddei, Hamid R. Sohrabi, Mark P. Molloy, David Ames, Paul Maruff, Christopher C. Rowe, Colin L. Masters, Ralph N. Martins

Summary: This study investigated the changes in several blood biomarkers across the AD continuum and their associations with cognitive decline and brain Aβ-PET load. The results showed that plasma Aβ1-42/Aβ1-40 ratio decreased, p-tau181 and GFAP increased in predicting the β-amyloid positive/negative status across the AD continuum.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

The relationship between objective physical activity and change in cognitive function

Kelsey R. R. Sewell, Stephanie R. R. Rainey-Smith, Jeremiah Peiffer, Hamid R. R. Sohrabi, Kevin Taddei, David Ames, Paul Maruff, Colin L. L. Masters, Christopher C. C. Rowe, Ralph N. N. Martins, Kirk I. I. Erickson, Belinda M. M. Brown

Summary: This study examined the association between objectively measured physical activity and cognition in older adults over 8 years. The results showed that higher energy expenditure, physical activity intensity, and total activity were associated with better episodic recall memory and global cognition. These findings suggest that physical activity may preserve cognitive function, with activity intensity playing a significant role.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A beta-PET, neurodegeneration, and cognition

Pratishtha Chatterjee, Lisa Vermunt, Brian A. Gordon, Steve Pedrini, Lynn Boonkamp, Nicola J. Armstrong, Chengjie Xiong, Abhay K. Singh, Yan Li, Hamid R. Sohrabi, Kevin Taddei, Mark Molloy, Tammie L. S. Benzinger, John C. Morris, Celeste Karch, Sarah Berman, Jasmeer Chhatwal, Carlos Cruchaga, Neill R. Graff-Radford, Gregory S. Day, Martin Farlow, Nick Fox, Alison Goate, Jason Hassenstab, Jae-Hong Lee, Johannes Levin, Eric McDade, Hiroshi Mori, Richard Perrin, Raquel Sanchez-Valle, Peter R. Schofield, Allan Levey, Mathias Jucker, Colin L. Masters, Anne M. Fagan, Randall J. Bateman, Ralph N. Martins, Charlotte Teunissen

Summary: This study found that plasma GFAP levels increase a decade before symptom onset in AD and are associated with Aβ load, neurodegeneration, and cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Medicine, General & Internal

Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL 18F-MK6240 PET study

Natasha Krishnadas, Vincent Dore, Joanne S. Robertson, Larry Ward, Christopher Fowler, Colin L. Masters, Pierrick Bourgeat, Jurgen Fripp, Victor L. Villemagne, Christopher C. Rowe

Summary: Tau accumulation in Alzheimer's disease (AD) occurs slowly and varies according to brain region and disease stage, plateauing at high levels. The rate of accumulation is best measured in the mesial temporal lobe and inferior temporal cortex in preclinical AD, and in large neocortical areas in mild cognitive impairment (MCI) and AD.

EBIOMEDICINE (2023)

Article Clinical Neurology

Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden

Pierrick Bourgeat, N. Krishnadas, V. Dore, R. Mulligan, R. Tyrrell, S. Bozinovski, K. Huang, J. Fripp, V. L. Villemagne, C. C. Rowe, Alzheimers Dis Neuroimaging Initiat, A. I. B. L. Res Grp

Summary: By matching cases from the Australian Imaging, Biomarkers and Lifestyle (AIBL) and Alzheimer's Disease Neuroimaging Initiative (ADNI) longitudinal cohort studies, F-18-MK6240 and F-18-flortaucipir (FTP) tau PET tracers were compared for longitudinal changes. The results showed that F-18-MK6240 is more sensitive to tau level changes in the preclinical stage of Alzheimer's disease.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2023)

Article Neurosciences

Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints

Hadeel Y. Tarawneh, Dona M. P. Jayakody, Shipra Verma, Vincent Dore, Ying Xia, Wilhelmina H. A. M. Mulders, Ralph N. Martins, Hamid R. Sohrabi

Summary: This study investigated whether auditory event-related potentials (AERPs) can be used to objectively identify older adults with subjective memory complaints (SMCs) who are at high risk of developing Alzheimer's disease (AD). The results suggest that P50 latencies may be a useful tool for identifying individuals at higher risk of developing measurable cognitive decline.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Neurosciences

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease

Pratishtha Chatterjee, Vincent Dore, Steve Pedrini, Natasha Krishnadas, Rohith Thota, Pierrick Bourgeat, Milos D. Ikonomovic, Stephanie R. Rainey-Smith, Samantha C. Burnham, Christopher Fowler, Kevin Taddei, Rachel Mulligan, David Ames, Colin L. Masters, Jurgen Fripp, Christopher C. Rowe, Ralph N. Martins, Victor L. Villemagne

Summary: Astrocyte reactivity is associated with the elevation of plasma glial fibrillary acidic protein (GFAP) and monoamine oxidase-B (MAO-B) in Alzheimer's disease. The association between plasma GFAP and regional F-18-SMBT-1 PET is dependent on brain β-amyloid (Aβ) load.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Geriatrics & Gerontology

The influence of baseline sleep on exercise-induced cognitive change in cognitively unimpaired older adults: A randomised clinical trial

Kelsey R. Sewell, Stephanie R. Rainey-Smith, Jeremiah Peiffer, Hamid R. Sohrabi, James Doecke, Natalie J. Frost, Shaun J. Markovic, Kirk Erickson, Belinda M. Brown

Summary: The study found that individuals with poorer sleep efficiency showed greater improvements in episodic memory and global cognition following a moderate intensity exercise intervention. This suggests that poor sleep may enhance the cognitive benefits of exercise interventions.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2023)

Article Clinical Neurology

Progression of cerebral amyloid angiopathy: a pathophysiological framework

Emma A. Koemans, Jasmeer P. Chhatwal, Susanne J. van Veluw, Ellis S. van Etten, Matthias J. P. van Osch, Marianne A. A. van Walderveen, Hamid R. Sohrabi, Mariel G. Kozberg, Zahra Shirzadi, Gisela M. Terwindt, Mark A. van Buchem, Eric E. Smith, David J. Werring, Ralph N. Martins, Marieke J. H. Wermer, Steven M. Greenberg

Summary: Cerebral amyloid angiopathy, a common age-related small vessel pathology, is associated with intracerebral haemorrhage and cognitive impairment. By studying individuals with different forms of the disease and using mouse models, researchers have identified key stages in the progression of cerebral amyloid angiopathy, which may help in developing interventions for this and other cerebral small vessel diseases.

LANCET NEUROLOGY (2023)

Article Clinical Neurology

A universal neocortical mask for Centiloid quantification

Pierrick C. Bourgeat, Vincent Dore, Christopher Rowe, Tammie S. Benzinger, Duygu Tosun, Manu Goyal, Pamela W. LaMontagne, Liang L. Jin, Michael Weiner, Colin L. Masters, Jurgen Fripp, Victor Villemagne

Summary: This study developed a universal mask for quantification of amyloid beta positron emission tomography tracers. There was a high overlap between the tracer-specific masks. The existing standard Centiloid mask is suitable for quantification of all amyloid beta tracers.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

Article Clinical Neurology

CenTauR: Toward a universal scale and masks for standardizing tau imaging studies

Victor Villemagne, Antoine Leuzy, Sandra Sanabria Bohorquez, Santiago Bullich, Hitoshi C. Shimada, Christopher Rowe, Pierrick Bourgeat, Brian Lopresti, Kun Huang, Natasha Krishnadas, Jurgen Fripp, Yuhei Takado, Alexandra Gogola, Davneet Minhas, Robby Weimer, Makoto Higuchi, Andrew Stephens, Oskar Hansson, Vincent Dore

Summary: This study developed multiple cortical tau tracers and generated a universal scale for cortical tau imaging. This universal scale allows for standardized quantitative measures of tau across different tracers and centers.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2023)

Proceedings Paper Computer Science, Artificial Intelligence

DBCE : A Saliency Method for Medical Deep Learning Through Anatomically-Consistent Free-Form Deformations

Joshua Peters, Leo Lebrat, Rodrigo Santa Cruz, Aaron Nicolson, Gregg Belous, Salamata Konate, Parnesh Raniga, Vincent Dore, Pierrick Bourgeat, Jurgen Mejan-Fripp, Clinton Fookes, Olivier Salvado

Summary: Deep learning models are powerful tools for medical imaging problems but interpreting their predictions can be difficult. In this paper, we propose DBCE, an explainability method that provides meaningful saliency maps for medical interpretations. We demonstrate its effectiveness in identifying disease-consistent atrophy patterns and show that it outperforms other saliency methods. Our method is also repeatable for different model initializations, which is an advantage over sensitivity-based methods.

2023 IEEE/CVF WINTER CONFERENCE ON APPLICATIONS OF COMPUTER VISION (WACV) (2023)

Article Clinical Neurology

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer's Continuum

A. Feizpour, V. Dore, J. D. Doecke, Z. S. Saad, G. Triana-Baltzer, R. Slemmon, P. Maruff, N. Krishnadas, P. Bourgeat, K. Huang, C. Fowler, S. R. Rainey-Smith, A. I. Bush, L. Ward, J. Robertson, R. N. Martins, C. L. Masters, V. L. Villemagne, J. Fripp, H. C. Kolb, Christopher C. Rowe

Summary: Plasma p217+tau can predict the rate of cognitive decline and has similar performance to PET Aβ and tau in predicting cognitive decline. Using p217+tau can significantly reduce the cost of clinical trials, especially in participant selection, compared to PET.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2023)

Review Neurosciences

Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease

Matin Ramezani, Malika Fernando, Shaun Eslick, Prita R. Asih, Sina Shadfar, Ekanayaka M. S. Bandara, Heidi Hillebrandt, Silochna Meghwar, Maryam Shahriari, Pratishtha Chatterjee, Rohith Thota, Cintia B. Dias, Manohar L. Garg, Ralph N. Martins

Summary: Alzheimer's disease is the most common form of dementia, characterized by cognitive dysfunction and behavioral changes. Pathological markers and neural damage in AD are associated with altered brain energy metabolism. The ketogenic diet has been shown to increase ketone body production, improving brain energy metabolism and potentially affecting AD biomarkers and neuroinflammation.

FRONTIERS IN NEUROSCIENCE (2023)

Article Geriatrics & Gerontology

Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults

Jun Yuan, Steve Pedrini, Rohith Thota, James Doecke, Pratishtha Chatterjee, Hamid R. Sohrabi, Charlotte E. Teunissen, Inge M. W. Verberk, Erik Stoops, Hugo Vanderstichele, Bruno P. Meloni, Christopher Mitchell, Stephanie Rainey-Smith, Kathryn Goozee, Andrew Chi Pang Tai, Nicholas Ashton, Henrik Zetterberg, Kaj Blennow, Junjie Gao, Delin Liu, Frank Mastaglia, Charles Inderjeeth, Minghao Zheng, Ralph N. Martins

Summary: This study investigated the association between plasma SOST levels and brain amyloid-beta load in older individuals. The results showed that plasma SOST levels were higher in individuals with brain amyloid-beta load, and the combination of plasma SOST and Aβ 42/Aβ40 ratio improved the predictive accuracy for preclinical Alzheimer's disease.

NPJ AGING (2023)

No Data Available